AstraZeneca vaccine injury victim slams U.K.’s inadequate payout scheme

A British woman who suffered a vaccine injury because of the AstraZeneca Wuhan coronavirus (COVID-19) injection has slammed the United Kingdom’s “woefully inadequate” Vaccine Damage Payment Scheme (VDPS).

Clare Bowie, 56, was hospitalized less than a month after being injected with the AstraZeneca COVID-19 vaccine. She received the vaccine on April 17, 2021 and was admitted on May 2 because of a mysterious spreading paralysis that eventually left her paralyzed from the chest down her body. The mother of three was subsequently forced to retire from her position as an administrative officer at the British Ministry of Defense for medical reasons.

Bowie was initially misdiagnosed with Guillain-Barre syndrome, a rare disorder where the immune system damages the nerves and has been linked to complications with the first dose of AstraZeneca. But it was later found that her condition was acute disseminated encephalitis complicated by transverse myelitis (ADEM), a rare condition causing inflammation in the brain and spinal cord. (Related: AstraZeneca admits its COVID-19 vaccine CAUSES BLOOD CLOTS in U.K. court filings.)

She fortunately managed to recover from the bout of ADEM, managing to move her left toe and foot in July 2021. Bowie began rehabilitation therapy in September 2021, and was discharged in December of that year. Nevertheless, she remains significantly disabled.

Bowie actually qualifies for the VDPS due to the vaccine injury she suffered. She and her husband did apply for the payment in October 2021, but did not receive the tax-free sum of £120,000 ($152,640) until February of last year – a year and a half after they filed the application.

Worse, she described the amount received from the VDPS as “woefully inadequate” and “traumatic for people” as it isn’t enough to cover the costs associated with her severe disability – including her mortgage and necessary home modifications.

“You think £120,000 ($152,640) is massive. I have been in the civil service all my life, I wasn’t used to that money,” said Bowie. “But the bottom line is it doesn’t clear your mortgage and modify your house.”

VDPS payout should be adjusted for inflation

Established in 1979, the VDPS provides financial compensation to individuals or their families adversely affected by vaccines. Initially offering £10,000 ($12,717), the payment amount has increased over the years, reaching its current level of £120,000 ($152,640) in 2007. However, inflation adjustments suggest this sum should be approximately £195,183 ($248,214) today.

Qualifying for the scheme is no walk in the park. The strict eligibility criteria requires individuals to be either killed or at least 60 percent disabled due to a vaccine. The severity of disability will be based on a doctor’s assessment and must include physical and mental impairments.

The scheme does not also scale payments based on the extent of disability. In other words, those completely paralyzed receive the same amount as those who only lost a limb. Worse, vaccine-damaged individuals who are deemed 59 percent or less disabled based on assessment are left without any compensation.

The VDPS is supposed to offer reassurance that the state will support those who suffer from vaccine-related injuries. While she benefited from the scheme and received a payout, Bowie fears for those less fortunate in proving their cases.

“The scheme is so unfair. They will tell someone they are not disabled enough, but the person could have been a marathon runner and now be unable to walk to the shops. Most people have mortgages at a few hundred thousand, so this figure doesn’t come anywhere close to clearing a normal mortgage.”

Head over to VaccineInjuryNews.com for more stories about individuals suffering from vaccine injuries.

Watch this video about the AstraZeneca COVID-19 vaccine being pulled off the market after being linked to blood clots and turbo cancer.

This video is from the Puretrauma357 channel on Brighteon.com.

More related stories:

AstraZeneca WITHDRAWS COVID-19 injection worldwide after admitting it causes BLOOD CLOTS.

AstraZeneca directs European Medicines Agency to revoke authorization for its own COVID-19 vaccine.

AstraZeneca COVID injection pulled from market worldwide after admission of link to mysterious clots.

AstraZeneca finally admits that their COVID-19 vaccine causes thrombosis with thrombocytopenia syndrome (TTS).

AstraZeneca begins advanced trials for COVID-19 antibody medication.

Sources include:

DailyMail.co.uk